Galectin Therapeutics Company
Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer.
Employee Number:
11-50
Funding Status:
IPO
Headquarters:
Norcross, Georgia, United States
Technology:
Biologics
Estimated Revenue:
Less than $1M
Founded Date:
2000
Industry:
PharmTech